Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Pharma
BMS leans on long-term growth drivers to dodge IRA impacts
Facing pressure from the IRA and falling sales for Abecma, BMS CEO Chris Boerner says the Beyenzi-maker had a "good start" with the first quarter.
Zoey Becker
Apr 25, 2024 12:57pm
BMS signs $380M deal with cell therapy manufacturer Cellares
Apr 22, 2024 11:10am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
BMS' Abecma wins earlier myeloma nod with updated boxed warning
Apr 5, 2024 11:46am
AbbVie retains top ad spending leadership in March
Apr 5, 2024 9:30am
BMS touts KRAS confirmatory trial win after Amgen's stumble
Mar 29, 2024 10:35am